ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $726,545 | -13.4% | 17,966 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $839,285 | -10.6% | 17,966 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $938,969 | +30.9% | 17,993 | +18.2% | 0.00% | 0.0% |
| Q2 2022 | $717,093 | -41.3% | 15,226 | -12.6% | 0.00% | 0.0% |
| Q1 2022 | $1,220,980 | +66.6% | 17,415 | +77.3% | 0.00% | – |
| Q4 2021 | $733,000 | +30.2% | 9,820 | -0.9% | 0.00% | – |
| Q3 2021 | $563,000 | +14.2% | 9,914 | -11.5% | 0.00% | – |
| Q2 2021 | $493,000 | -10.2% | 11,201 | +0.6% | 0.00% | – |
| Q1 2021 | $549,000 | +12.3% | 11,136 | -4.2% | 0.00% | – |
| Q4 2020 | $489,000 | -4.9% | 11,626 | +3.5% | 0.00% | -100.0% |
| Q3 2020 | $514,000 | -8.5% | 11,237 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $562,000 | -7.0% | 11,453 | -2.4% | 0.00% | 0.0% |
| Q1 2020 | $604,000 | -5.9% | 11,737 | +13.0% | 0.00% | 0.0% |
| Q4 2019 | $642,000 | -0.6% | 10,390 | -3.1% | 0.00% | 0.0% |
| Q3 2019 | $646,000 | -29.2% | 10,719 | -0.9% | 0.00% | 0.0% |
| Q2 2019 | $913,000 | -13.4% | 10,815 | -2.0% | 0.00% | 0.0% |
| Q1 2019 | $1,054,000 | +46.2% | 11,031 | +8.3% | 0.00% | 0.0% |
| Q4 2018 | $721,000 | -23.1% | 10,183 | -7.2% | 0.00% | 0.0% |
| Q3 2018 | $938,000 | -35.0% | 10,971 | -12.0% | 0.00% | -50.0% |
| Q2 2018 | $1,444,000 | +53.6% | 12,460 | +7.3% | 0.00% | +100.0% |
| Q1 2018 | $940,000 | +33.1% | 11,610 | -3.5% | 0.00% | 0.0% |
| Q4 2017 | $706,000 | +26.1% | 12,025 | +0.4% | 0.00% | 0.0% |
| Q3 2017 | $560,000 | +25.3% | 11,974 | -3.7% | 0.00% | 0.0% |
| Q2 2017 | $447,000 | +16.1% | 12,428 | -0.6% | 0.00% | – |
| Q1 2017 | $385,000 | +3.8% | 12,509 | +13.0% | 0.00% | -100.0% |
| Q4 2016 | $371,000 | +25.8% | 11,068 | -0.3% | 0.00% | – |
| Q3 2016 | $295,000 | +20.4% | 11,104 | -0.1% | 0.00% | – |
| Q2 2016 | $245,000 | -19.9% | 11,117 | +3.6% | 0.00% | – |
| Q1 2016 | $306,000 | -12.6% | 10,731 | +1.4% | 0.00% | – |
| Q4 2015 | $350,000 | -7.7% | 10,579 | +1.0% | 0.00% | – |
| Q3 2015 | $379,000 | -17.2% | 10,475 | +2.9% | 0.00% | -100.0% |
| Q2 2015 | $458,000 | +110.1% | 10,182 | +42.7% | 0.00% | – |
| Q1 2015 | $218,000 | -37.7% | 7,136 | +3.7% | 0.00% | -100.0% |
| Q4 2014 | $350,000 | +25.4% | 6,881 | -2.4% | 0.00% | – |
| Q3 2014 | $279,000 | -7.0% | 7,052 | +1.0% | 0.00% | – |
| Q2 2014 | $300,000 | +125.6% | 6,979 | +110.7% | 0.00% | – |
| Q1 2014 | $133,000 | +4333.3% | 3,312 | +2995.3% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 107 | -16.4% | 0.00% | – |
| Q2 2013 | $2,000 | – | 128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |